Chromophil Renal Cell Carcinoma - 25 Studies Found
Recruiting |
: Cabozantinib-S-Malate, Crizotinib, Volitinib, or Sunitinib Malate in Treating Patients With Locally Advanced or Metastatic Kidney Cancer :
: |
Active, not recruiting |
: Bevacizumab With or Without TRC105 in Treating Patients With Metastatic Kidney Cancer :
|
Terminated |
: Sorafenib and Interferon Alfa in Treating Patients With Locally Advanced or Metastatic Kidney Cancer :
|
Recruiting |
: CREATE: Cross-tumoral Phase 2 With Crizotinib :
|
Active, not recruiting |
: Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell Transplant :
|
Active, not recruiting |
: Total-Body Irradiation and Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer :
|
Active, not recruiting |
: Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer :
|
Recruiting |
: A Dose Escalation, Safety and Activity Study of CDX-014 in Patients With Advanced or Metastatic Renal Cell Carcinoma :
|
Completed |
: Sorafenib Tosylate and Bevacizumab in Treating Patients With Advanced Kidney Cancer :
|
Completed |
: Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors :
|